[1]
Oliveira, A.G. de and Silveira, D. 2018. MEDICINE FOR TREATMENT OF HEPATITIS C: FROM THE APPROVAL OF GENERIC DRUG SOFOSBUVIR BY ANVISA TO SOCIAL AND COMMERCIAL DIFFICULTIES. Infarma - Pharmaceutical Sciences. 30, 3 (Dec. 2018), 143–145. DOI:https://doi.org/10.14450/2318-9312.v30.e3.a2018.pp143-145.